Shakhinur Islam Mondal

Dr. Shakhinur Islam Mondal

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Advances and Applications in Bioinformatics and Chemistry
Verified
Journal Article
Open access
PDF file
SMShakhinur Islam Mondal
Shakhinur Islam Mondal
SFSabiha Ferdous
Sabiha Ferdous
AAArzuba Akter
Arzuba Akter
ZMZabed Mahmud
Zabed Mahmud
NKNurul Karim
Nurul Karim
TATanzila Afrin
Tanzila Afrin
Bacterial enteric infections resulting in diarrhea, dysentery, or enteric fever constitute a huge public health problem, with more than a billion episodes of disease annually in developing and developed countries. In this study, the deadly agent of hemorrhagic diarrhea and hemolytic uremic syndrome, Escherichia coli O157:H7 was investigated with extensive computational approaches aimed at identifying novel and broad-spectrum antibiotic targets. A systematic in silico workflow consisting of comparative genomics, metabolic pathways analysis, and additional drug prioritizing parameters was used to identify novel drug targets that were essential for the pathogen’s survival but absent in its human host. Comparative genomic analysis of Kyoto Encyclopedia of Genes and Genomes annotated metabolic pathways identified 350 putative target proteins in E. coli O157:H7 which showed no similarity to human proteins. Further bioinformatic approaches including prediction of subcellular localization, calculation of molecular weight, and web-based investigation of 3D structural characteristics greatly aided in filtering the potential drug targets from 350 to 120. Ultimately, 44 non-homologous essential proteins of E. coli O157:H7 were prioritized and proved to have the eligibility to become novel broad-spectrum antibiotic targets and DNA polymerase III alpha (dnaE) was the top-ranked among these targets. Moreover, druggability of each of the identified drug targets was evaluated by the DrugBank database. In addition, 3D structure of the dnaE was modeled and explored further for in silico docking with ligands having potential druggability. Finally, we confirmed that the compounds N-coeleneterazine and N-(1,4-dihydro-5H-tetrazol-5-ylidene)-9-oxo-9H-xanthene-2-sulfonamide were the most suitable ligands of dnaE and hence proposed as the potential inhibitors of this target protein. The results of this study could facilitate the discovery and release of new and effective drugs against E. coli O157:H7 and other deadly human bacterial pathogens.

17 June 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TKTahsin Khan
Tahsin Khan
RIRahatul Islam
Rahatul Islam
TJTarhima Jahan Jerin
Tarhima Jahan Jerin
AMAraf Mahmud
Araf Mahmud
SKSahara Khatun
Sahara Khatun
SMShakhinur Islam Mondal
Shakhinur Islam Mondal
West Nile Virus (WNV) is a life threatening flavivirus that causes significant morbidity and mortality worldwide. No preventive therapeutics including vaccines against WNV are available for human use. In this study, immunoinformatics approach was performed to design a multi epitope-based subunit vaccine against this deadly pathogen. Human (HLA) and Mice (H-2) allele specific potential T-cell and B-cell epitopes were shortlisted through a stringent procedure. Molecular docking showed selected epitopes that have stronger binding affinity with human TLR-4. Molecular dynamics simulation confirmed the stable nature of the docked complex. Furthermore, in silico cloning analysis ensures efficient expression of desired gene in the microbial system. Interestingly, previous studies showed that two of our selected epitopes have strong immune response against WNV. Therefore, selected epitopes could be strong vaccine candidates to prevent WNV infections in human. However, further in vitro and in vivo investigations could be strengthening the validation of the vaccine candidate against WNV.

Verified
Journal Article
Open access
PDF file
SMShakhinur Islam Mondal
Shakhinur Islam Mondal
AAArzuba Akter
Arzuba Akter
LDLorraine Draper
Lorraine Draper
RRR. Paul Ross
R. Paul Ross
CHColin Hill
Colin Hill
Clostridioides difficile is a spore-forming enteric pathogen causing life-threatening diarrhoea and colitis. Microbial disruption caused by antibiotics has been linked with susceptibility to, and transmission and relapse of, C. difficile infection. Therefore, there is an urgent need for novel therapeutics that are effective in preventing C. difficile growth, spore germination, and outgrowth. In recent years bacteriophage-derived endolysins and their derivatives show promise as a novel class of antibacterial agents. In this study, we recombinantly expressed and characterized a cell wall hydrolase (CWH) lysin from C. difficile phage, phiMMP01. The full-length CWH displayed lytic activity against selected C. difficile strains. However, removing the N-terminal cell wall binding domain, creating CWH351—656, resulted in increased and/or an expanded lytic spectrum of activity. C. difficile specificity was retained versus commensal clostridia and other bacterial species. As expected, the putative cell wall binding domain, CWH1—350, was completely inactive. We also observe the effect of CWH351—656 on preventing C. difficile spore outgrowth. Our results suggest that CWH351—656 has therapeutic potential as an antimicrobial agent against C. difficile infection.

31 August 2022 in Microbiology Spectrum
Verified
Journal Article
Open access
TKTahsin Khan
Tahsin Khan
AMAraf Mahmud
Araf Mahmud
MHMahmudul Hasan
Mahmudul Hasan
KAKazi Faizul Azim
Kazi Faizul Azim
MBMusammat Kulsuma Begum
Musammat Kulsuma Begum
SMShakhinur Islam Mondal
Shakhinur Islam Mondal
Legionella pneumophila is a human pathogen distributed worldwide, causing Legionnaires’ disease (LD), a severe form of pneumonia and respiratory tract infection. L. pneumophila is emerging as an antibiotic-resistant strain, and controlling LD is now difficult. Hence, developing novel drugs and vaccines against L. pneumophila is a major research priority.

11 April 2017 in In Silico Pharmacology
Verified
Journal Article
Open access
SMShakhinur Islam Mondal
Shakhinur Islam Mondal
ZMZabed Mahmud
Zabed Mahmud
MEMontasir Elahi
Montasir Elahi
AAArzuba Akter
Arzuba Akter
NJNurnabi Azad Jewel
Nurnabi Azad Jewel
TKTaisei Kikuchi
Taisei Kikuchi
Protein–protein interaction (PPI) and host–pathogen interactions (HPI) proteomic analysis has been successfully practiced for potential drug target identification in pathogenic infections. In this research, we attempted to identify new drug target based on PPI and HPI computation approaches and subsequently design new drug against devastating enterohemorrhagicEscherichia coliO104:H4 C277-11 (Broad), which causes life-threatening food borne disease outbreak in Germany and other countries in Europe in 2011. Our systematic in silico analysis on PPI and HPI ofE. coliO104:H4 was able to identify bacteriald-galactose-binding periplasmic and UDP-N-acetylglucosamine 1-carboxyvinyltransferase as attractive candidates for new drug targets. Furthermore, computational three-dimensional structure modeling and subsequent molecular docking finally proposed [3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-d]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide)] and (6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one) as promising candidate drugs for further evaluation and development forE. coliO104:H4 mediated diseases. Identification of new drug target would be of great utility for humanity as the demand for designing new drugs to fight infections is increasing due to the developing resistance and side effects of current treatments. This research provided the basis for computer aided drug design which might be useful for new drug target identification and subsequent drug design for other infectious organisms.

17 June 2014 in Interdisciplinary Sciences: Computational Life Sciences
Verified
Journal Article
Closed access
PDF file
SMShakhinur Islam Mondal
Shakhinur Islam Mondal
BKBijendra Khadka
Bijendra Khadka
AAArzuba Akter
Arzuba Akter
PRPradip Kumar Roy
Pradip Kumar Roy
RSRazia Sultana
Razia Sultana